Answers are grounded in this paper and cite their sources.
Cardiac amyloidosis (CA) describes the pathological process of amyloid protein deposition in the extracellular space of the myocardium. Unfortunately, the diagnosis of CA is often made late and when the disease process is advanced. However, advances in cardiovascular imaging have allowed for better prognostication and establishing diagnostic pathways with high sensitivity and specificity. This review discusses the role of echocardiography, cardiac MRI and nuclear cardiology in current clinical practice for diagnosis and prognosis of CA.
No takes yet. Share an insight, caveat, or question.
Agha et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: